Delivery Order SPE2DB22D2007-SPE2DB25FJ3HU
- Not listed
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,117.29 for VELTASSA 8.4 GM Powder Packet 30s, a pharmaceutical product used in medical treatment. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,510.17 firm fixed price contract is for the delivery of Veltassa 8.4 GM Powder Packet 30S, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order was awarded under an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,147.51 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of VELTASSA 8.4 GM POWDER PACKET 30S, a specialty pharmaceutical product, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,456.26 Firm Fixed Price Delivery Order, awarded on December 9, 2024, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VELTASSA 8.4 GM POWDER PACKET 30S. The contract has a firm fixed price of $3,395.25 and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veltassa 8.4 GM powder packets. The contract has a ceiling value of $5,092.31 and an ultimate completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VELTASSA 8.4 GM POWDER PACKETS. The contract has a total ceiling value of $1,936.65 and runs through May 6, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,231.03 firm fixed-price delivery order is for the supply of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a $2,037.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide VELTASSA 8.4 GM POWDER PACKET 30S. The contract has an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp is a for-profit organization and an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3HUDelivery Order
The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical commodities to support military healthcare systems globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare needs. This delivery order represents one of numerous competitively awarded transactions under the company's DLA prime contract portfolio, which encompasses a wide range of therapeutic products including specialty medications, brand-name and generic drugs, and medical supplies. The company's federal contract history demonstrates capability in fulfilling diverse medical supply requirements for organizations including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/25/25 |